|
Re: 5 point MACE
|
5
|
Resverlogix Corp.
|
Mar 22, 2019 10:28AM
|
|
Re: time to add/3 vs 5 pt. MACE
|
5
|
Resverlogix Corp.
|
Mar 21, 2018 03:14PM
|
|
Resverlogix Presents at Clinical Trials in Alzheimer’s Disease (CTAD) Asia 2018
|
5
|
Resverlogix Corp.
|
Sep 04, 2018 08:54AM
|
|
Re: Questions for BearDownAZ
|
5
|
Resverlogix Corp.
|
Jul 23, 2015 10:23PM
|
|
Re: AHA Posters are published
|
5
|
Resverlogix Corp.
|
Nov 16, 2020 10:26AM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
5
|
Resverlogix Corp.
|
Dec 22, 2020 10:31AM
|
|
Re: Could BETonMACE Cognition Sub-Study be presented at AAIC this month?
|
5
|
Resverlogix Corp.
|
Jul 03, 2019 10:32AM
|
|
Re: Rock Stars still rocking it
|
5
|
Zenith Epigenetics
|
Jun 06, 2018 09:25AM
|
|
Re: U.S. Listing
|
5
|
Resverlogix Corp.
|
Dec 12, 2018 02:03PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
5
|
Resverlogix Corp.
|
Sep 14, 2017 01:53PM
|
|
Re: Update
|
5
|
Zenith Epigenetics
|
Jul 12, 2017 01:26PM
|
|
Re: Agm
|
5
|
Resverlogix Corp.
|
Dec 14, 2017 04:37PM
|
|
Importance of hard 3-point MACE endpoints
|
5
|
Resverlogix Corp.
|
Mar 19, 2018 03:32PM
|
|
Re: Resverlogix Announces Corporate Update Conference Call & Webcast on June 10, 2020 and Upcoming Presentation at the 57th ERA-EDTA Virtual Congress on
|
5
|
Resverlogix Corp.
|
Jun 05, 2020 07:27PM
|
|
Re: AGM
|
5
|
Resverlogix Corp.
|
Sep 12, 2018 04:20PM
|
|
Re: Three Months - Yeah, Right.
|
5
|
Resverlogix Corp.
|
Jul 19, 2017 10:08AM
|
|
The runway is clear....
|
5
|
Resverlogix Corp.
|
Dec 05, 2018 04:13PM
|
|
Re: BETonMACE Enrollment
|
5
|
Resverlogix Corp.
|
Dec 14, 2017 04:51PM
|
|
Re: archived presentation is up. still no audio
|
5
|
Resverlogix Corp.
|
Nov 18, 2019 02:12PM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
5
|
Resverlogix Corp.
|
Sep 11, 2017 11:21AM
|
